IPO-话题@MedSci

#IPO#

54篇内容 | 1950人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1510819, encodeId=afa1151081961, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=美图IPO，沙利文俱乐部又添独角兽，不同的领域同样的杰出, objectType=article, longId=84477, objectId=7ba7844e7dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ba7844e7dd, replyNumber=0, likeNumber=92, createdTime=2016-12-17, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ba7844e7dd, moduleTitle=美图IPO，沙利文俱乐部又添独角兽，不同的领域同样的杰出, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ba7844e7dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510818, encodeId=1ac11510818c2, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=诺华新一代免疫调节剂BAF312（siponimod）治疗继发进展型多发性硬化症（SPMS）III期临床获得成功, objectType=article, longId=75977, objectId=1959e5977e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1959e5977e7, replyNumber=0, likeNumber=66, createdTime=2016-08-28, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1959e5977e7, moduleTitle=诺华新一代免疫调节剂BAF312（siponimod）治疗继发进展型多发性硬化症（SPMS）III期临床获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1959e5977e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510817, encodeId=e1a5151081ebe, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=解析跌落凡间的华大基因：创业板IPO募资仅17.32亿, objectType=article, longId=60972, objectId=9f8c609e25c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f8c609e25c, replyNumber=0, likeNumber=90, createdTime=2015-12-23, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f8c609e25c, moduleTitle=解析跌落凡间的华大基因：创业板IPO募资仅17.32亿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f8c609e25c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510816, encodeId=87951510816a4, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Lancet：转移胰腺导管腺癌患者，Nanoliposomal irinotecan联合氟尿嘧啶和叶酸一起服用效果如何？, objectType=article, longId=59307, objectId=561e5930e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=561e5930e4e, replyNumber=0, likeNumber=58, createdTime=2015-11-24, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=561e5930e4e, moduleTitle=Lancet：转移胰腺导管腺癌患者，Nanoliposomal irinotecan联合氟尿嘧啶和叶酸一起服用效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=561e5930e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510815, encodeId=90fe151081510, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=全球首家在线问诊公司IPO 中国版差距很大, objectType=article, longId=52867, objectId=7d4e5286e99, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d4e5286e99, replyNumber=0, likeNumber=63, createdTime=2015-07-05, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d4e5286e99, moduleTitle=全球首家在线问诊公司IPO 中国版差距很大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d4e5286e99)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510814, encodeId=6ea3151081458, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Seres：开启人类微生物组IPO时代, objectType=article, longId=51467, objectId=9d185146e96, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d185146e96, replyNumber=0, likeNumber=62, createdTime=2015-06-03, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d185146e96, moduleTitle=Seres：开启人类微生物组IPO时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d185146e96)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510813, encodeId=a91c15108135d, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Bipolar Disord：双相感情障碍对预期寿命的影响, objectType=article, longId=49871, objectId=c6b6498e16f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6b6498e16f, replyNumber=0, likeNumber=58, createdTime=2015-04-27, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6b6498e16f, moduleTitle=Bipolar Disord：双相感情障碍对预期寿命的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6b6498e16f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510812, encodeId=29201510812be, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=甘李药业获高盛撑腰却在IPO门前摔倒, objectType=article, longId=37736, objectId=cab13e7360a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cab13e7360a, replyNumber=0, likeNumber=67, createdTime=2014-07-13, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cab13e7360a, moduleTitle=甘李药业获高盛撑腰却在IPO门前摔倒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cab13e7360a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510811, encodeId=b2f41510811e5, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=贝达药业冲刺IPO 两明星PE “坐享其成”, objectType=article, longId=37010, objectId=af1b3e01076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1b3e01076, replyNumber=0, likeNumber=83, createdTime=2014-06-27, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1b3e01076, moduleTitle=贝达药业冲刺IPO 两明星PE “坐享其成”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af1b3e01076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510810, encodeId=c3041510810e5, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=贝达药业冲刺IPO 两明星PE “坐享其成”, objectType=article, longId=36908, objectId=dde036908f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dde036908f9, replyNumber=0, likeNumber=127, createdTime=2014-06-26, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dde036908f9, moduleTitle=贝达药业冲刺IPO 两明星PE “坐享其成”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dde036908f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510809, encodeId=8c861510809a2, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=BIPOLAR DISORD ：不同临床亚型双相障碍患的生物学差异, objectType=article, longId=12093, objectId=24081209361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24081209361, replyNumber=0, likeNumber=100, createdTime=2012-12-01, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24081209361, moduleTitle=BIPOLAR DISORD ：不同临床亚型双相障碍患的生物学差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24081209361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510808, encodeId=eb4b1510808fd, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Injury：胫骨远端骨折MIPO手术如何防止大隐静脉/隐神经损伤, objectType=article, longId=8776, objectId=47698e7637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47698e7637, replyNumber=0, likeNumber=72, createdTime=2012-08-11, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47698e7637, moduleTitle=Injury：胫骨远端骨折MIPO手术如何防止大隐静脉/隐神经损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47698e7637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510807, encodeId=6c6c151080e02, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Ann Neurol:大脑中的12/15-lipoxygenase可能是控制阿尔茨海默症的关键靶标, objectType=article, longId=3796, objectId=7cf93e9654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cf93e9654, replyNumber=0, likeNumber=74, createdTime=2012-01-31, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cf93e9654, moduleTitle=Ann Neurol:大脑中的12/15-lipoxygenase可能是控制阿尔茨海默症的关键靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cf93e9654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510806, encodeId=621c151080698, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=外科单孔腹腔镜TriPort技术进展, objectType=article, longId=2444, objectId=cee6244494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cee6244494, replyNumber=0, likeNumber=74, createdTime=2011-04-04, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cee6244494, moduleTitle=外科单孔腹腔镜TriPort技术进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cee6244494)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IPO

2020-05-29

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

美图IPO，沙利文俱乐部又添独角兽，不同的领域同样的杰出

2016-12-17

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

诺华新一代免疫调节剂BAF312（siponimod）治疗继发进展型多发性硬化症（SPMS）III期临床获得成功

2016-08-28

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

解析跌落凡间的华大基因：创业板IPO募资仅17.32亿

2015-12-23

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Lancet：转移胰腺导管腺癌患者，Nanoliposomal irinotecan联合氟尿嘧啶和叶酸一起服用效果如何？

2015-11-24

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

全球首家在线问诊公司IPO 中国版差距很大

2015-07-05

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Seres：开启人类微生物组IPO时代

2015-06-03

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Bipolar Disord：双相感情障碍对预期寿命的影响

2015-04-27

仁心济世 (审核中...)

前往app查看评论内容

#IPO#

甘李药业获高盛撑腰却在IPO门前摔倒

2014-07-13

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

贝达药业冲刺IPO 两明星PE “坐享其成”

2014-06-27

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

贝达药业冲刺IPO 两明星PE “坐享其成”

2014-06-26

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

BIPOLAR DISORD ：不同临床亚型双相障碍患的生物学差异

2012-12-01

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Injury：胫骨远端骨折MIPO手术如何防止大隐静脉/隐神经损伤

2012-08-11

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Ann Neurol:大脑中的12/15-lipoxygenase可能是控制阿尔茨海默症的关键靶标

2012-01-31

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

外科单孔腹腔镜TriPort技术进展

2011-04-04

科室
- - 订阅+
  - 更多科室
工具
服务